On September 15, Bibet Pharma announced that Daniel A. Castro officially joined BeBetter Pharma Inc., an American subsidiary of the company on September 14, 2026, as Chief Commercial Officer, responsible for the company's global business development strategy, international cooperation, external licensing and strategic partnership building, and to help promote the company's US business platform and international team building.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.